Cargando…

Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach

BACKGROUND: Estimation of Influenza vaccine effectiveness (VE) varies with study design, clinical outcome considered and statistical methodology used. By estimating VE using differing outcomes and statistical methods on the same cohort of individuals the variability in the estimates produced can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanagh, Kimberley, Robertson, Chris, McMenamin, Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244414/
https://www.ncbi.nlm.nih.gov/pubmed/22216108
http://dx.doi.org/10.1371/journal.pone.0028743
_version_ 1782219726710112256
author Kavanagh, Kimberley
Robertson, Chris
McMenamin, Jim
author_facet Kavanagh, Kimberley
Robertson, Chris
McMenamin, Jim
author_sort Kavanagh, Kimberley
collection PubMed
description BACKGROUND: Estimation of Influenza vaccine effectiveness (VE) varies with study design, clinical outcome considered and statistical methodology used. By estimating VE using differing outcomes and statistical methods on the same cohort of individuals the variability in the estimates produced can be better understood. The Pandemic Influenza Primary Care Reporting (PIPeR) cohort of approximately 193,000 individuals was used to estimate pandemic VE in Scotland during season 2009–10. VE results for three outcomes; influenza related consultations, virological confirmed influenza and death were considered. Use of individualised records allowed all models to be adjusted for age, sex, deprivation, risk status relating to chronic illnesses, seasonal vaccination status and a marker of the individual's propensity to consult. For the consultation and death outcomes, VE was calculated by comparing consultation rates in the unvaccinated and vaccinated groups, adjusted for the listed factors, using both Cox and Poisson regression models. For the consultation outcome, the unvaccinated group was split into individuals before vaccination and those never vaccinated to allow for potential differences in the health seeking behaviour of these groups. For the virology outcome estimates were calculated using a generalised additive logistic regression model. All models were adjusted for time. Vaccine effect was demonstrated for the influenza-like illness consultation outcome using the Cox model (VE = 49% 95% CI (19%, 67%)) with lower estimates from the model splitting the before and never vaccinated groups (VE = 34.2% with 95% CI (−0.5%, 58.9%)). Vaccine effect was also illustrated for overall mortality (VE = 40% (95% CI 18%, 56%)) and a virological confirmed subset of symptomatic individuals (VE = 60% (95% CI −38%, 89%)). CONCLUSIONS: This study illustrates positive point estimates of Influenza VE across methodology and outcome for a single cohort of individuals during season 2009–10. Understanding of potential differences between approaches aids interpretation of VE results in future seasons.
format Online
Article
Text
id pubmed-3244414
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32444142012-01-03 Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach Kavanagh, Kimberley Robertson, Chris McMenamin, Jim PLoS One Research Article BACKGROUND: Estimation of Influenza vaccine effectiveness (VE) varies with study design, clinical outcome considered and statistical methodology used. By estimating VE using differing outcomes and statistical methods on the same cohort of individuals the variability in the estimates produced can be better understood. The Pandemic Influenza Primary Care Reporting (PIPeR) cohort of approximately 193,000 individuals was used to estimate pandemic VE in Scotland during season 2009–10. VE results for three outcomes; influenza related consultations, virological confirmed influenza and death were considered. Use of individualised records allowed all models to be adjusted for age, sex, deprivation, risk status relating to chronic illnesses, seasonal vaccination status and a marker of the individual's propensity to consult. For the consultation and death outcomes, VE was calculated by comparing consultation rates in the unvaccinated and vaccinated groups, adjusted for the listed factors, using both Cox and Poisson regression models. For the consultation outcome, the unvaccinated group was split into individuals before vaccination and those never vaccinated to allow for potential differences in the health seeking behaviour of these groups. For the virology outcome estimates were calculated using a generalised additive logistic regression model. All models were adjusted for time. Vaccine effect was demonstrated for the influenza-like illness consultation outcome using the Cox model (VE = 49% 95% CI (19%, 67%)) with lower estimates from the model splitting the before and never vaccinated groups (VE = 34.2% with 95% CI (−0.5%, 58.9%)). Vaccine effect was also illustrated for overall mortality (VE = 40% (95% CI 18%, 56%)) and a virological confirmed subset of symptomatic individuals (VE = 60% (95% CI −38%, 89%)). CONCLUSIONS: This study illustrates positive point estimates of Influenza VE across methodology and outcome for a single cohort of individuals during season 2009–10. Understanding of potential differences between approaches aids interpretation of VE results in future seasons. Public Library of Science 2011-12-21 /pmc/articles/PMC3244414/ /pubmed/22216108 http://dx.doi.org/10.1371/journal.pone.0028743 Text en Kavanagh et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kavanagh, Kimberley
Robertson, Chris
McMenamin, Jim
Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach
title Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach
title_full Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach
title_fullStr Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach
title_full_unstemmed Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach
title_short Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach
title_sort assessment of the variability in influenza a(h1n1) vaccine effectiveness estimates dependent on outcome and methodological approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244414/
https://www.ncbi.nlm.nih.gov/pubmed/22216108
http://dx.doi.org/10.1371/journal.pone.0028743
work_keys_str_mv AT kavanaghkimberley assessmentofthevariabilityininfluenzaah1n1vaccineeffectivenessestimatesdependentonoutcomeandmethodologicalapproach
AT robertsonchris assessmentofthevariabilityininfluenzaah1n1vaccineeffectivenessestimatesdependentonoutcomeandmethodologicalapproach
AT mcmenaminjim assessmentofthevariabilityininfluenzaah1n1vaccineeffectivenessestimatesdependentonoutcomeandmethodologicalapproach